V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011793 | 310003819 | 1.74 | 80.9 | Palliative (P) | 2019-06-30 | 2019-07-21 | Bevacizumab 7.5mg/kg | 02 | N | 310007768 | BEVACIZUMAB |
| 310011794 | 310007571 | 1.66 | 70 | Palliative (P) | null | 2019-03-20 | Bevacizumab | N | N | 310007894 | BEVACIZUMAB |
| 310011795 | 310003866 | 1.81 | null | Palliative (P) | null | 2016-03-01 | CHOP - 21 days | N | N | 310008352 | CHOP |
| 310011797 | 310003976 | null | 78.8 | Palliative (P) | 2017-06-24 | 2018-02-23 | GEMCITABINE | 2 | N | 310010225 | GEMCITABINE |
| 310011798 | 310010607 | 1.88 | null | Disease modification (D) | 2018-05-11 | 2018-05-22 | GEMCITABINE | N | N | 310010231 | GEMCITABINE |
| 310011800 | 310004051 | 1.54 | 70.8 | Palliative (P) | 2017-08-17 | 2018-02-28 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 310012172 | CISPLATIN + GEMCITABINE |
| 310011801 | 310004093 | null | 82.5 | Disease modification (D) | 2017-01-18 | 2017-01-27 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 310013153 | NOT MATCHED |
| 310011802 | 310004117 | 1.78 | 60.4 | Curative (C) | 2016-07-01 | 2016-07-02 | BEAM | N | N | 310014178 | BEAM |
| 310011804 | 310004192 | 1.68 | null | Palliative (P) | 2018-04-01 | 2018-04-06 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310014972 | GEMCITABINE |
| 310011805 | 310004198 | 1.94 | 91.8 | null | null | 2018-08-11 | CISPLATIN + GEMCITABINE | N | N | 310014991 | CISPLATIN + GEMCITABINE |
| 310011806 | 310009647 | 1.81 | null | Disease modification (D) | 2016-10-20 | 2016-10-29 | BEAM | 02 | N | 310015428 | BEAM |
| 310011807 | 310004321 | 1.8 | 90.3 | Curative (C) | 2021-03-21 | 2021-03-28 | BEAM | N | N | 310016231 | BEAM |
| 310011809 | 310004368 | 1.57 | 52.3 | Palliative (P) | 2014-10-04 | 2016-08-24 | Bexarotene | N | N | 310016833 | BEXAROTENE |
| 310011810 | 310004416 | 1.67 | 59 | Palliative (P) | 2015-10-13 | 2015-10-14 | ALL UKALL2011 Ind B Sht Dex (PAsp) | N | N | 310017276 | UKALL2011 |
| 310011811 | 310004448 | 1.76 | 80.2 | Palliative (P) | 2018-04-30 | 2018-05-17 | Ipilimumab | 2 | null | 310017474 | IPILIMUMAB |
| 310011813 | 310011252 | 1.82 | 82.2 | Disease modification (D) | 2018-12-17 | 2018-12-17 | Cisplatin | 02 | N | 310018383 | CISPLATIN |
| 310011814 | 310004625 | 1.77 | 69.2 | Palliative (P) | 2018-09-01 | 2018-09-02 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 01 | N | 310018446 | CARBOPLATIN + ETOPOSIDE |
| 310011815 | 310007973 | 1.9 | null | Curative (C) | 2014-12-07 | 2014-12-08 | Docetaxel + Gemcitabine with GCSF | 99 | null | 310018467 | DOCETAXEL + GEMCITABINE |
| 310011816 | 310004643 | 1.55 | 72.7 | Curative (C) | 2020-01-18 | 2020-01-18 | Carboplatin + Etoposide IV 3 day | N | null | 310018478 | BEXAROTENE |
| 310011817 | 310004653 | 1.86 | 77.2 | Palliative (P) | 2017-08-25 | 2017-08-28 | Cisplatin | null | null | 310018504 | CISPLATIN |
| 310011818 | 310010728 | 1.79 | 79.2 | Curative (C) | 2019-08-11 | 2019-09-18 | Docetaxel | N | N | 310018871 | DOCETAXEL |
| 310011819 | 310008067 | 1.64 | 10.6 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-06 | ESHAP | 02 | N | 310018968 | BEXAROTENE |
| 310011820 | 310008075 | 1.7 | 50.3 | Adjuvant (A) | 2015-05-30 | 2015-07-17 | Bexarotene | null | null | 310018998 | ESHAP |
| 310011821 | 310004834 | null | null | Palliative (P) | 2017-01-17 | 2018-07-28 | Cyclophosphamide High Dose | N | N | 310019038 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011822 | 310008097 | 1.7 | 57.9 | Palliative (P) | 2013-02-13 | 2015-06-09 | Etoposide oral | N | N | 310019139 | ETOPOSIDE |
| 310011823 | 310004912 | null | 54.5 | Palliative (P) | 2014-03-03 | 2014-03-03 | Cisplatin 7 day | N | N | 310019371 | CISPLATIN |
| 310011824 | 310008122 | 1.68 | 58.3 | Palliative (P) | 2018-01-20 | 2018-01-25 | Carboplatin + Etoposide IV 3 day | null | null | 310019376 | BEXAROTENE |
| 310011825 | 310008146 | null | 68 | Palliative (P) | 2018-02-26 | 2018-03-12 | ESHAP | 02 | N | 310019511 | UKALL2011 |
| 310011826 | 310008165 | 1.71 | 58 | Palliative (P) | 2016-03-05 | 2016-04-13 | DABRAFENIB | N | N | 310019617 | CAPECITABINE + IRINOTECAN |
| 310011827 | 310008171 | 1.74 | null | Palliative (P) | 2015-10-14 | 2015-10-28 | FLAG + Idarubicin | 02 | N | 310019675 | ALEMTUZUMAB |
| 310011828 | 310005001 | 1.65 | 65.7 | Curative (C) | 2015-04-14 | 2015-04-24 | INCA TRIAL | 02 | N | 310019677 | IMATINIB |
| 310011830 | 310010763 | null | 71 | Palliative (P) | 2017-10-24 | 2018-03-26 | ECX | 02 | N | 310019697 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310011831 | 310009891 | null | 92.7 | Palliative (P) | 2017-08-07 | 2017-09-03 | ECX | N | N | 310020170 | METHOTREXATE |
| 310011832 | 310005252 | 1.48 | 52 | Curative (C) | null | 2018-05-27 | Depocyte Intrathecal | N | N | 310024543 | PEG INTERFERON |
| 310011833 | 310005266 | 1.78 | 54.9 | Palliative (P) | 2019-04-09 | 2019-04-09 | Temozolomide 200mg/m2 | 02 | N | 310024633 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 310011834 | 310005291 | 1.86 | 72 | Palliative (P) | 2015-06-06 | 2015-12-02 | Capecitabine (14 day) + Irinotecan | N | N | 310024934 | ECX |
| 310011835 | 310005297 | null | null | Curative (C) | 2019-06-08 | 2019-06-18 | Cisplatin + Topotecan | null | null | 310024973 | CARBOPLATIN + PEMETREXED |
| 310011836 | 310005331 | 1.65 | 58.1 | Palliative (P) | 2014-09-30 | 2014-10-02 | Chlorambucil | N | N | 310025291 | EVEROLIMUS |
| 310011837 | 310005340 | 1.76 | 79.2 | Curative (C) | 2017-05-08 | 2017-05-20 | EP | N | N | 310025341 | CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 310011838 | 310005366 | 1.62 | 76.9 | Palliative (P) | 2017-01-07 | 2017-01-13 | PERTUZUMAB + TRASTUZUMAB | N | N | 310025608 | OCTOPUS TRIAL |
| 310011839 | 310008368 | 1.54 | null | Palliative (P) | 2016-03-27 | 2016-12-16 | DABRAFENIB + TRAMETINIB | 02 | N | 310025710 | PREDNISOLONE + VINBLASTINE + RITUXIMAB |
| 310011840 | 310005392 | 1.56 | 47.3 | Palliative (P) | 2016-09-11 | 2016-10-15 | MTX HD + PROCARBAZINE + VINCRISTINE | null | null | 310025719 | VEMURAFENIB |
| 310011841 | 310005410 | null | 70.2 | Curative (C) | null | 2018-07-22 | Trabectedin | N | N | 310000469 | DOXORUBICIN |
| 310011842 | 310008409 | 1.57 | 71 | Curative (C) | 2019-04-21 | 2019-06-09 | Trabectedin | N | N | 310003601 | ICON8B TRIAL |
| 310011843 | 310005476 | 1.61 | 53.2 | Palliative (P) | null | 2019-08-14 | TRASTUZUMAB | N | N | 310003761 | GEMCITABINE + OXALIPLATIN |
| 310011844 | 310005490 | 1.87 | 87.7 | Disease modification (D) | 2016-05-14 | 2016-05-21 | Doxorubicin 75mg/m2 | 02 | N | 310005975 | DACARBAZINE |
| 310011845 | 310008433 | 1.7 | 73.6 | Not known (9) | 2013-09-17 | 2014-11-18 | Eribulin | 02 | N | 310007558 | TEMOZOLOMIDE |
| 310011846 | 310008442 | 1.65 | null | Palliative (P) | 2016-08-31 | 2016-08-31 | Cytarabine intrathecal | null | null | 310011231 | CTD |
| 310011847 | 310010006 | 1.96 | null | Adjuvant (A) | 2018-04-25 | 2018-05-02 | ECF | 2 | N | 310012353 | METHOTREXATE |
| 310011848 | 310005578 | 1.55 | 62 | Palliative (P) | 2019-03-16 | 2019-03-17 | Hydroxycarbamide | Y | N | 310021471 | IPILIMUMAB + NIVOLUMAB |